Odyssey Therapeutics, Inc. (ODTX) earnings
Quarterly results of Odyssey Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 6 quarters, the latest results release and when the next one is expected.
Next earnings date
Odyssey Therapeutics, Inc. is expected to report around January 13, 2027. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Odyssey Therapeutics, Inc. reported revenue of $0 and a net loss of $53.1M.
Diluted earnings per share were -$1.10.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $0 | - | -$53.1M | -$1.10 |
| Q2 FY2026 | $0 | - | -$52.8M | -$1.74 |
| Q1 FY2026 | $0 | - | -$38.3M | -$6.77 |
| Q3 FY2026 | $99K | - | -$35.5M | -$7.78 |
| Q2 FY2026 | $959K | - | -$41.2M | -$29.54 |
| Q1 FY2026 | $1.9M | - | -$38.4M | -$39.37 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Odyssey Therapeutics, Inc.'s next earnings date?
Odyssey Therapeutics, Inc. is expected to report around January 13, 2027. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
What were Odyssey Therapeutics, Inc.'s latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, Odyssey Therapeutics, Inc. reported revenue of $0 and a net loss of $53.1M. The figures come from its filing with the SEC.
Get an email when ODTX reports
Follow ODTX and we email you its next results the day they are filed, with the numbers explained.